Girish Naganathan - 08 Nov 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP Chief Technology Officer
Signature
By: Christophe Cantenot For: Girish Naganathan
Issuer symbol
DXCM
Transactions as of
08 Nov 2022
Net transactions value
+$31.45
Form type
4
Filing time
14 Nov 2022, 15:51:09 UTC
Previous filing
11 Oct 2022
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $31.45 +31,449 $0.001000* 31,449 08 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in four equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2 Included in this number are 31,449 unvested restricted stock units, 31,449 of which were granted on November 8, 2022 and shall vest through November 8, 2026.